Products with
Anticancer bioactivity
Cat.No.
|
Product Name
|
BCN3757 |
Viniferin
|
1. α-Viniferin has anti-oxidant and anticancer activities.
2. ɛ-Viniferin and vincristine can enhance the anti-tumor effects efficiently by inducing HepG2 cell apoptosis.
3. α-Viniferin strongly inhibits the activities of the two CYPs dose dependently.
4. α-Viniferin suppresses the expression of proinflammatory genes iNOS and COX-2 in the early stage of inflammation by inhibiting the Akt/PI3K-dependent NF-κB activation
and inhibits the production of proinflammatory mediators NO and PGE2 in the late stage by stimulating Nrf2-mediated HO-1 signaling pathway in LPS-stimulated BV2 microglial cells. |
BCN3764 |
Kansuiphorin C
|
1. Kansuiphorin C shows cytotoxic activity. |
BCN3765 |
Kansuinine A
|
1. Kansuinine A possesses analgesic props.
2. Kansuinine A shows NGF inducing activity. |
BCN3766 |
Kansuinine B
|
1. Kansuinine B shows cytotoxic activity.
2. Kansuinine B shows analgesic activity.
3. Treatment with kansuinine B and kansuinine A represents a novel method to block the IL-6-induced effects. |
BCN3771 |
Jolkinolide A
|
Jolkinolide A has anti-tumor activity. It inhibited VEGF expression in A549 cells through the inhibition of the Akt-STAT3-mTOR signaling pathway, and directly inhibited the proliferation and migration of HUVECs. |